The Association between the Anti-inflammatory Protein CC10 and Smoking Status among Participants in a Chemoprevention Trial
- 1 March 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (3), 577-583
- https://doi.org/10.1158/1055-9965.epi-06-0923
Abstract
CC10, the secretory product of bronchiolar Clara cells, is infrequently expressed in non–small cell lung cancer (NSCLC), and its overexpression in NSCLC cell lines results in a less malignant phenotype. CC10 levels in bronchoalveolar lavage fluid (BAL) and serum are significantly lower in current smokers than healthy nonsmokers, but the effect of long-term smoking cessation on CC10 is unknown. We measured CC10 in baseline BAL and plasma collected from current (n = 81) and former (n = 23) smokers participating in a chemoprevention trial. Former smokers had significantly higher plasma CC10 levels compared with current smokers [mean, 62.1 ng/mL (95% CI, 43.0-81.2); range, 23.0-175.0 ng/mL for former smokers; and mean, 37.1 ng/mL (95% CI, 29.8-44.4); range, 5.0-171.0 ng/mL for current smokers; P < 0.001]. BAL CC10 levels also trended in the same direction. A significant positive correlation was found between CC10 plasma and BAL levels. After adjustment for age, sex, and pack-years of cigarette consumption, former smokers had 1.70 (95% CI, 1.23-2.36) times higher plasma CC10 levels than current smokers (P < 0.01), whereas former smokers also had nonsignificantly higher baseline BAL CC10 levels compared with current smokers [adjusted mean ratio (95% CI), 1.60 (0.92-2.80), P = 0.094 and 1.35 (0.86-2.10), P = 0.193 for the absolute and normalized BAL CC10, respectively]. These results show that sustained smoking cessation is associated with higher plasma CC10 levels, suggesting that at least some of the damage associated with tobacco smoke may be repaired by long-term smoking cessation. (Cancer Epidemiol Biomarkers Prev 2007;16(3):577–83)Keywords
This publication has 39 references indexed in Scilit:
- Mice lacking uteroglobin are highly susceptible to developing pulmonary fibrosisFEBS Letters, 2006
- Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectinJournal of Cellular Physiology, 2006
- Non-invasive biomarkers of pulmonary damage and inflammation: Application to children exposed to ozone and trichloramineToxicology and Applied Pharmacology, 2005
- Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identificationProteomics, 2005
- A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial EpitheliumClinical Cancer Research, 2004
- Increased Susceptibility of Mice Lacking Clara Cell 10-kDa Protein to Lung Tumorigenesis by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a Potent Carcinogen in Cigarette SmokePublished by Elsevier BV ,2004
- Serum pneumoproteins and biomarkers of exposure to urban air pollution: a cross-sectional comparison of policemen and forestersBiomarkers, 2004
- Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16Biomarkers, 2003
- DNA Repair Activity for Oxidative Damage and Risk of Lung CancerJNCI Journal of the National Cancer Institute, 2003
- Decrease of serum Clara cell protein in smokersThe Lancet, 1992